Partnerships for Environmental Public Health (PEPH)
As a network, PEPH highlights funding opportunity announcements from NIEHS, from other institutes and centers (ICs) at the National Institutes of Health (NIH) and from other Federal partners. This section lists and describes the various funding opportunity announcements that are PEPH-related. This list will change as new funding opportunity announcements are released and others close.
NIEHS encourages investigators to submit project applications using the unsolicited research grant process (e.g., R01s). Unsolicited, investigator-initiated proposals are sent to NIH for review at the Center for Scientific Review (CSR). There are many Integrated Review Groups (IRGs) at CSR; however, those most likely to be appropriate for PEPH-related unsolicited applications include the Population Sciences and Epidemiology IRG and the Healthcare Delivery and Methodologies IRG.
When preparing your proposal, we highly encourage you to do the following:
- Gain an understanding of the grant submission and review process at NIH by visiting the CSR's Applicant Resources webpage.
- View the National Cancer Institute'sApply for a Grant webpage.
- View the National Library of Medicine’s NIH Grant Tutorials.
- Talk with NIEHS program staff to get feedback on the IRG and study section that is the best fit for your proposal.
- Check out the NIEHS's Instructions and Resources for Applicants to get additional information.
Current Available Funding Opportunities
PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Invites eligible United States small business concerns to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Direct to Phase II (NIH only), Fast-Track (NIH only), and Phase IIB (NIH only) grant applications. The PHS 2023 -2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA represent scientific program areas that may be of interest to applicant small businesses in the development of projects that have potential for commercialization. Small business concerns that have the research capabilities and technological expertise to contribute to the research and development mission(s) of the NIH and CDC awarding components identified in this funding opportunity are encouraged to submit SBIR grant applications in these areas. A related SBIR funding opportunity is available without a clinical trial requirement: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed). Related funding opportunities are available for small business applicants interested in submitting small business technology transfer (STTR) applications: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) and PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required).
Deadlines: January 5, 2024; April 5, 2024
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
Encourages applications from small business concerns to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The funding opportunity aims to facilitate the transition of previously or currently funded Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the small business concern is expected to maintain oversight and management of research and development throughout the award.
Deadlines: January 5, 2024; April 5, 2024
The Office of the Assistant Secretary for Health and the Office of Minority Health are seeking community-led strategies and tools to address health disparities in communities disproportionately impacted by environmental risks and hazards including those related to climate change, and the cumulative impacts of other stressors. This Challenge seeks to support to community-based and Tribal organizations in areas including, but not limited to: development or implementation community-driven strategies to address health disparities; effective partnerships between community-based or Tribal organizations and other civil organizations, such as faith-based, healthcare and public health and educational organizations, to address environmental and climate change-related hazards and support community resilience; and innovative approaches to building capacity in community-based or Tribal organizations on project planning, needs assessment, budgeting, engagement with community members, and grant application writing, to address environmental and climate change-related hazards as drivers of health disparities. The competition has two phases. All eligible submissions will be evaluated, and separate prizes will be awarded for each of the two phases. The first phase is currently open for submissions.
Deadline: January 30, 2024
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp — Clinical Trial Not Allowed)
Supports administrative supplements to recruit and support high school, undergraduate and graduate/clinical students, postbaccalaureate and post-master’s individuals, postdoctoral researchers (including health professionals), and eligible investigators. NIH encourages institutions to diversify their student, postdoctoral researchers, and faculty populations to enhance the participation of individuals from groups that are underrepresented in the biomedical, clinical, behavioral, and social sciences, such as individuals from racial and ethnic groups that have been underrepresented in the sciences; individuals with disabilities; individuals from disadvantaged backgrounds; and women from disadvantaged backgrounds. See the NIEHS workforce diversity supplements webpage for more information.
Deadline: February 1, 2024
ReWARD funding will support research in areas related to the programmatic interests of NIEHS and ongoing diversity, equity, inclusion, and accessibility activities focused on enhancing diversity in the biomedical research enterprise within the U.S. and territories. This funding is intended for individuals with no current NIH research project grant funding at the time of the award. This announcement requires a Plan for Enhancing Diverse Perspectives as part of the application.
Deadline: February 5, 2024
Notice of Special Interest: Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility Mentorship
Supports administrative supplements to existing NIH awards to support scientists who have demonstrated compelling commitments and contributions to mentorship and enhancing diversity, equity, inclusion, and accessibility (DEIA) in the biomedical sciences. This Notice of Special Interest (NOSI) encourages program directors and principal investigators to promote DEIA and mentorship broadly and as such differs from a Diversity Supplement (PA-23-189). Diversity supplements are designed to support research experiences for individuals from diverse backgrounds, including those from underrepresented groups, through the career continuum from high school to the faculty level. In contrast, this NOSI focuses on mentors who have dedicated their time and effort and have made significant contributions, based on evaluation data and publications, to DEIA. Mentors are encouraged to apply for an administrative supplement to further their personal research and/or mentoring activities.
Deadline: February 16, 2024
Supports research on interventions to improve health in Native American populations. This includes 1) etiologic research that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests interventions for health promotion, prevention, treatment, or recovery, and 3) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. The inclusion of Native American investigators serving on the study team or as the program director or principal investigator is strongly encouraged. This funding opportunity is part of the Intervention Research to Improve Native American Health initiative, which also includes Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) and Intervention Research to Improve Native American Health (R34 Clinical Trial Optional). For the R01 and R21 funding mechanisms, NIEHS is interested in applications that focus on the development, adaptation, efficacy, effectiveness, implementation, or sustainability of culturally appropriate interventions to prevent or mitigate the health impacts of environmental exposures that disproportionately impact Native American populations. For the R34 funding mechanism, NIEHS is interested in applications that support the initial development of a culturally appropriate clinical trial or research project in preparation for health promotion or disease prevention interventions addressing the health impacts of environmental exposures that impact Native American populations.
Deadline: October 1, 2024